FREE SHIPPING When you spend over $100
Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.
Roche Accuchek Performa Control Solution
Unit: SET
$38.99
Accu-Chek Guide Me
Unit: EACH
$48.99
Roche AccuChek Guide Test Strip Bx100
Unit: BX100
$86.99
Roche Accuchek Safe-T-Pro
Unit: BX200
$81.99
Roche Accuchek Performa Strips 100s
Unit: PKT100
$71.30
Roche Accutrend Plus Cholesterol Strips
Unit: PKT25
$98.00
Roche Accutrend Plus Meter
Unit: EACH
$595.00
Roche Accutrend Plus Triglycerides Strip
Unit: PKT
$98.00
Roche Accutrend Plus Lactate Strip
Unit: BX25
$105.00
Accuchek Fastclix
Unit: PACK
$16.99
Accuchek Softclix
Unit: PACK
$43.20
Roche
The combined strengths of pharmaceuticals and diagnostics under one roofhave made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the twelfth consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2020 employed about 98,000 people worldwide. In 2020, Roche invested CHF 12.2 billion in R&D and posted sales of CHF 58.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.